Rokit Healthcare Set for Imminent Human Clinical Surgery for Kidney Regeneration... Aiming for Treatment Approval This Year
Development of Kidney Regeneration Technology Using Autologous Omentum-Derived Cells
Initial Safety and Regenerative Potential to Be Evaluated, with Approval for Advanced Regenerative Medicine Treatment Sought in Q4
Rokit Healthcare is set to begin human clinical surgeries for kidney regeneration technology, moving forward with commercialization.
Rokit Healthcare announced on the 12th that it recently received clinical approval for advanced regenerative medicine related to kidney regeneration at the Korean Society of Nephrology (KSN) academic conference and plans to commence the world’s first human clinical surgery for kidney regeneration in July.
The company is developing a kidney regeneration platform utilizing autologous omentum-derived cells. In this clinical trial, the initial safety and regenerative potential of the omentum patch will be evaluated.
According to Rokit Healthcare, this technology combines AI-based 3D bioprinting with robotic surgery. Based on four years of accumulated clinical results, the company explained that the omentum patch has been classified as low-risk by the Advanced Regenerative Medicine Committee and that surgical safety has been verified through large animal robotic surgery studies. The company plans to seek approval for regenerative medicine treatment in the fourth quarter of this year.
At the Korean Society of Nephrology academic conference, the medical community continued to show strong interest in the kidney regeneration platform. The company stated that, during the conference, medical professionals and researchers from both Korea and abroad expressed interest in joint research and the future process of securing clinical data.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
An official from Rokit Healthcare said, "Through the human clinical trials scheduled for July, we plan to verify safety and regenerative potential and subsequently proceed with the treatment approval process."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.